Literature DB >> 23817705

Trust but verify: trial registration and determining fidelity to the protocol.

Deborah A Zarin, Tony Tse.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 23817705     DOI: 10.7326/0003-4819-159-1-201307020-00011

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  11 in total

1.  The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta-analyses.

Authors:  John P A Ioannidis
Journal:  Milbank Q       Date:  2016-09       Impact factor: 4.911

2.  Unfounded Claims of Improved Functional Outcomes Attributed to Follistatin Gene Therapy in Inclusion Body Myositis.

Authors:  Steven A Greenberg
Journal:  Mol Ther       Date:  2017-09-08       Impact factor: 11.454

3.  Update on Trial Registration 11 Years after the ICMJE Policy Was Established.

Authors:  Deborah A Zarin; Tony Tse; Rebecca J Williams; Thiyagu Rajakannan
Journal:  N Engl J Med       Date:  2017-01-26       Impact factor: 91.245

4.  Desirability and feasibility of wireless electronic monitoring of medications in clinical trials.

Authors:  William N Robiner; Nancy Flaherty; Thyra A Fossum; Thomas E Nevins
Journal:  Transl Behav Med       Date:  2015-09       Impact factor: 3.046

5.  Phylotocol: Promoting Transparency and Overcoming Bias in Phylogenetics.

Authors:  Melissa B DeBiasse; Joseph F Ryan
Journal:  Syst Biol       Date:  2019-07-01       Impact factor: 15.683

6.  Using ClinicalTrials.gov to supplement information in ophthalmology conference abstracts about trial outcomes: a comparison study.

Authors:  Roberta W Scherer; Lynn Huynh; Ann-Margret Ervin; Kay Dickersin
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

7.  ClinicalTrials.gov as a data source for semi-automated point-of-care trial eligibility screening.

Authors:  Pascal B Pfiffner; JiWon Oh; Timothy A Miller; Kenneth D Mandl
Journal:  PLoS One       Date:  2014-10-21       Impact factor: 3.240

8.  Animal Study Registries: Results from a Stakeholder Analysis on Potential Strengths, Weaknesses, Facilitators, and Barriers.

Authors:  Susanne Wieschowski; Diego S Silva; Daniel Strech
Journal:  PLoS Biol       Date:  2016-11-10       Impact factor: 8.029

9.  Comparison of primary endpoints between publications, registries, and protocols of phase III cancer clinical trials.

Authors:  Fei Liang; Xinmei Guo; Sheng Zhang; Hongxi Xue; Qiang Chen; Xichun Hu
Journal:  Oncotarget       Date:  2017-10-03

10.  Publication proportions for registered breast cancer trials: before and following the introduction of the ClinicalTrials.gov results database.

Authors:  Innocent Gerald Asiimwe; Dickson Rumona
Journal:  Res Integr Peer Rev       Date:  2016-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.